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Abstract
Purpose In most forms of open angle glaucoma, the
trabecular meshwork is the main barrier for aqueous humor
outflow, causing elevated intraocular pressure (IOP). The
Trabectome is a minimal invasive device for the surgical
treatment of open angle glaucoma, particularly eliminating
the juxtacanalicular meshwork. This study was conducted to
compare the effectiveness and complication profile among
different glaucoma subgroups.
Methods Single center prospective observational study. There
were 557 consecutive eyes of 487 patients included in this
study. Trabectome surgery was performed either alone or in
combination with cataract surgery. Intraoperative and
postoperative complications were documented systematically.
Main outcomemeasures were IOP reduction over time and the
preoperative and postoperative number of IOP-lowering
medications. Due to subgroup sizes, only data from eyes with
primary open angle glaucoma and pseudoexfoliation
glaucoma were processed for statistical analysis.
Results For the 261 eyes classified as primary open angle
glaucoma, preoperative IOP was 24±5.5 mmHg (mean ±
SD) under 2.1±1.3 IOP-lowering medications. After a mean
follow-up of 204±238 days, IOP was reduced to 18±
6.1 mmHg, and medication was reduced to 1.2±1.1. For the
173 eyes classified as pseudoexfoliation glaucoma, after a
mean follow-up of 200±278 days, IOP was reduced from
25±5.9 mmHg to 18±8.2 mmHg, and medication was
reduced from 2.0±1.2 to 1.1±1.1. A Cox proportional hazards
model hinted forward superiority of the combined surgery
cases (Trabectome+Phaco+intraocular lens) in comparison
to Trabectome surgery only in phakic or pseudophakic eyes.
No serious complications were observed.
Conclusions Minimal invasive glaucoma surgery with the
Trabectome seems to be safe and effective. The subgroup
analysis of different kinds of open angle glaucomas presented
in this study may help in first-line patient selection. The lack
of ocular surface alterations makes it a valuable addition to
glaucoma surgery.
Keywords Primary and secondary open angle glaucoma .
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Introduction
Glaucoma is one of the leading causes for irreversible
blindness worldwide [1]. So far, the only proven therapy to
slow down the process of optic nerve atrophy is to lower
intraocular pressure. Classic glaucoma filtration surgery by
means of trabeculectomy or episcleral aqueous drainage
implants is the most effective way of lowering intraocular
pressure permanently down to low-normal levels. Although
both surgical procedures are well established, potentially
dangerous intraoperative and postoperative complications
might appear in non-negligible frequency. This has led to the
development of non-penetrating glaucoma surgery (NPGS)
and, more recently, minimal invasive glaucoma surgery. The
minimal invasive surgical approach does not alter the
conjunctiva, acts in a postoperatively closed and therefore
stable eye, offers an excellent opportunity for combined
cataract-glaucoma surgery and is further characterized by a
minimized intraoperative and postoperative risk profile.
The Trabectome uses a minimal-invasive, gonioscopic
clear-cornea surgical approach to reduce outflow resistance
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by removing the juxtacanalicular trabecular meshwork. This is
altered pathologically in different forms of glaucoma, acting
more as a barrier for the aqueous than as an active and
regulative tissue as it is known to be in healthy eyes. Collector
channels in the scleral wall of Schlemm’s canal are exposed to
the anterior chamber and recruited for aqueous drainage into
the scleral and episcleral venous plexus.
This prospective, non-comparative study is to report
comprehensive follow-up data after Trabectome surgery in
different forms of open angle glaucoma.
Methods
Ethics statement This prospective non-randomized
observational study was approved by the local ethics
committee (University of Freiburg Ethics Committee No.
235/10_160678) and followed the regulations of GCP and
the Declaration of Helsinki. It was designed as an analysis
of effectiveness contrary to a controlled efficacy analysis.
After written informed consent, a total of 557 consecutive
eyes of 487 Caucasian patients were included from June 2009
to June 2013. In the eyes included, intraocular pressure (IOP)
was uncontrolled under topical and/or systemic antiglaucoma
medication. Target pressure for these eyes was a reduction in
intraocular pressure by at least 20 % from baseline. With the
Trabectome, postoperative IOP values below 15 mmHg are
unlikely to be achieved. Therefore, absolute target pressures
below 15 mmHg were considered as not suitable for inclusion
into this study. Patients presenting with a concomitant cataract
(visual acuity ≤20/32) were offered combined surgery
(Trabectome + phacoemulsification + intraocular lens).
Surgery was performed by two surgeons (JFJ and MN)
using the Trabectome® system, including the Trabectome
single-use handpiece including an irrigation-aspiration (I/
A) system (Neomedix Inc., Tustin, USA). In combined
surgery, the Trabectome surgery was performed prior to
phacoemulsification. After topical anaesthesia using
proxymetacainehydrochloride eye drops (Proparakain-POS
0.5 %®, Ursapharm, Germany), a 1.7 mm clear cornea tunnel
was made; lidocain 1 % (Xylocain®, AstraZeneca, Germany)
was instilled into the anterior chamber for intraocular
anesthesia.
A methylcellulose-based viscoelastic (Ocucoat®, Bausch
& Lomb) was used in all cases to stabilize the anterior
chamber during surgery as recommended by the manufacturer
of the Trabectome. Surgery was performed under gonioscopic
control using the modified Swan-Jacob-Lens. The trabecular
meshwork was removed over 90 to 120° starting with a power
of 0.8 W, increasing in steps of 0.1 until the electrosurgical
effect allowed smooth removal of the juxtacanalicular tissue
without tearing. Viscoelastic was removed using the provided
I/A-system with a modified Simco-cannula.
Pilocarpine 2 % eye drops, a topical steroid and antibiotic
ointment were instilled after surgery. All eyes were given
Pilocarpine 2 % tid for the first week after surgery, and bid
thereafter for four more weeks. Steroid eyedrops (prednisolone
1 %) were given five times daily or more frequently in the case
of stronger postoperative intraocular reflux bleeding during the
first week after surgery. Steroids were tapered over four weeks
after surgery. Intraocular pressure (IOP)-lowering medication
was given topically or systemically according to individual
postoperative IOP-levels.
Intraocular pressure was recorded in amasked fashion using
Goldmann applanation tonometry. Values were recorded by an
independent person. IOP measurements were recorded on
postoperative day one, after one week, one month, and every
three months thereafter.
Absolute success was defined as a reduction of IOP from
baseline of at least 20 % without the need of additional
medication. Qualified success was a reduction of IOP from
baseline of at least 20 % with or without the need for topical
antiglaucomatous medication. Data was collected using an
intranet-based relational database.
To account for censoring, we estimated the cumulative
percentages of absolute and qualified success as well as the
failure rates over time with the Kaplan-Meier method.
Differences between subgroups were tested with the logrank
statistics. Statistical significance was assumed for p ≤0.05.We
fitted a Cox proportional hazards model to assess the risk
factors for failure or subsequent glaucoma surgery in that
eye. We, i.e., tested whether cataract surgery at time of
Trabectome surgery is beneficial contrary to performing
Trabectome in pseuophacic eyes against the background of
age at time of surgery and glaucoma entities.
Results
A total of 557 eyes of 487 patients have been included in
this comprehensive effectiveness analysis. Please see
Table 1 for the detailed demographic data and descriptive
statistics on all patients. Due to the small sample size of
most glaucoma entities, further subgroup analysis was only
performed for the eyes classified as Primary Open Angle
Glaucoma (POAG, n =261) and the eyes classified as
Pseudoexfoliation Glaucoma (XFG, n =173).
Figure 1 shows the Kaplan-Meier cumulative survival
analysis, displaying absolute success (Fig. 1a; Δ IOP≥-20 %
from baseline, no medication) and qualified success (Fig. 1b;
Δ IOP≥-20 % from baseline, topical medication allowed) over
time. For qualified success, the difference between the two
groups proved to be statistically significant at p =0.01.
Intraocular pressure (IOP) and number of topical
medications (qualified success) over the follow-up period
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are displayed for POAG (Fig. 2) and for XFG (Fig. 3).
Groups are sub-classified as phakic or pseudophakic at the
time of Trabectome surgery, or having undergone combined
Trabectome – cataract (Trabectome + phaco + intraocular
lens) surgery.
We further analyzed the effectiveness after Trabectome–
only surgery in phakic and pseudophakic eyes, as well as
the effectiveness of the combined surgery (Trabectome +
Phacoemulsification + intraocular lens implantation). A
Cox proportional hazards model (corrected for age and lens
state) hints towards superiority of the combined surgery
over the Trabectome-only surgery when performed in either
phakic or pseudophakic eyes (Table 2).
No severe intraoperative and postoperative complications
were observed. Minor events included reflux bleeding that
occurred in 92 % of patients and resolved spontaneously. Only
two patients needed one lavage of the anterior chamber to
remove the blood. This was not associated with failure.
However, there was one case of intraoperative ciliolenticular
block that occurred during anterior chamber lavage with
acetylcholine (Miochol-E®, Bausch & Lomb). It resolved under
postoperative topical cycloplegic treatment. No postoperative
hypotony (defined as an IOP<6 mmHg) was observed. Eight
percent of patients presented with an acute postoperative rise in
IOP (>30 mmHg) that was controlled with temporary systemic
carboanhydrase inhibitors (CAI). Three patients developed
clinically evident cystoidmacular edema after combined surgery
that resolved under topical anti-inflammatory treatment
(prednisolone and diclofenac eye-drops) and systemic
carboanhydrase inhibitor. IOP values measured under systemic
CAI therapy were not collected for statistical analysis.
For the patients of failed Trabectome surgery, a subsequent
trabeculectomy with Mitomycin C was performed with a
formerly untouched conjunctiva due to uncontrolled IOP. In
two patients, a second Trabectome approach was performed
but did not result in any further IOP reduction. In both cases,
this was followed by a trabeculectomy.
Discussion
In this prospective, noncomparative study, the Trabectome
seems to be a safe method of minimal invasive glaucoma
surgery. Our data also hint towards the effectiveness in
reducing IOP and postoperative number of medications.
In the 261 consecutive eyes classified as primary open angle
glaucoma, we reached an overall IOP reduction of 25%, with a
simultaneous reduction in antiglaucoma medication of 43 %.
For the 173 eyes classified as pseudoexfoliation glaucoma, we
found an overall IOP reduction of 30 % with a simultaneous
reduction in medication of 44 %. The Cox proportional
hazards model correcting for age and lens state hinted towards
Fig. 1 a Absolute success:
Kaplan-Meier cumulative
survival of all eyes classified as
Primary Open Angle Glaucoma
(POAG) or Pseudoexfoliation
Glaucoma (XFG) over time,
absolute success (ΔIOP≥-20 %
from baseline, no additional IOP
lowering medication). Please note
the steep drop of the Kaplan-
Meier curve for both, POAG and
XFG, resembling the persistent
need for topical medication after
Trabectome surgery in most eyes.
b Qualified success: Kaplan-
Meier cumulative survival of all
eyes classified as Primary Open
Angle Glaucoma (POAG) or
Pseudoexfoliation Glaucoma
(XFG) over time, qualified
success ((ΔIOP≥-20 % from
baseline, topical medication
allowed). The difference between
the two groups was significant at
p =0.01
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superiority of the combined surgery cases (Trabectome +
Phaco + IOL), with a trend towards younger age being a risk
factor for subsequent glaucoma surgery.
In the literature, the largest published data pool consists
of 1127 eyes, a mixed population of different subgroups of
open angle glaucomas [2]. These data were collected and
published in affiliation with Neomedix Inc. In 738 of these
eyes, only Trabectome surgery (without cataract extraction)
was performed. After two years of observation, the IOP was
reduced by 40 % (n =46), medication could be reduced by
60 %. In 366 of the eyes, Trabectome surgery was
performed in combination with cataract surgery. Starting
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Fig. 2 a Postoperative IOP data (ordinate [mmHg]) over time (abscissa
[days after surgery]) from eyes classified as POAG, given separately for
the eyes being phakic or pseudophakic at the time of Trabectome surgery,
and for the eyes having undergone combined cataract and Trabectome
surgery. Time ‘0’ gives the preoperative IOP value. N (below abscissa)
gives the number of patients included at each time point. b Qualified
success: Number of postoperative topical medications needed (ordinate
[n]) over time (abscissa [days after surgery]) from eyes classified as
POAG, given separately for the eyes being phakic or pseudophakic at
the time of Trabectome surgery, and for the eyes having undergone
combined cataract and Trabectome surgery. Time ‘0’ gives the
preoperative number of topical medications
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with a lower baseline IOP, it was reduced by 20 % with a
concomitant reduction in medication by 57 %. Also, 78 %
of all patients had intraoperative reflux bleeding from the
collector channels. During the follow-up period, 5.9 % of
patients had to be converted to trabeculectomy, and 1.6 %
needed glaucoma implant surgery due to uncontrolled IOP.
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Fig. 3 a Postoperative IOP data (ordinate [mmHg]) over time (abscissa
[days after surgery]) from eyes classified as XFG, given separately for the
eyes being phakic or pseudophakic at the time of Trabectome surgery, and
for the eyes having undergone combined cataract and Trabectome
surgery. Time ‘0’ gives the preoperative IOP value. N (below abscissa)
gives the number of patients included at each time point. b Qualified
success: Number of postoperative topical medications needed (ordinate
[n]) over time (abscissa [days after surgery]) from eyes classified as XFG,
given separately for the eyes being phakic or pseudophakic at the time of
Trabectome surgery, and for the eyes having undergone combined
cataract and Trabectome surgery. Time ‘0’ gives the preoperative number
of topical medications
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Yet another study with comparable preoperative IOP-
values reports on the 1-year success rate after Trabectome
surgery alone and after combined surgery. In the Trabectome
group (n =538), intraocular pressure was reduced by 31 %
(26.3±7.7 mmHg→16.6±4 mmHg), the concomitant
medications by 28 % (n =2.9±1.3→n =2.1±1.4). In the
combined surgery group (n =290), the reduction in IOP was
only 23 % (to 15.6±3.7 mmHg), with a preoperative baseline
of 20.2±6 mmHg. Medication was reduced by 33% (n =2.5±
1.1→n =1.7±1.3). 65 % of the Trabectome group and 87 %
of the phaco-Trabectome group met the criterion of qualified
[3].
Ting et al., compared the outcomes of eyes classified as
POAG or XFG, either after Trabectome surgery alone or after
combined surgery by a retrospective, central database
analysis[4]. For POAG, 450 Trabectome only and 263
combined surgery cases were included. After one year, IOP
was reduced from 25.5±8 mmHg to 16.8±4 mmHg (−34 %)
and from 19.9±5 mmHg to 15.6±3 mmHg (−22 %),
medication was reduced by 18.5 % and 29 %, respectively.
For XFG, in the 67 Trabectome only eyes, IOP was reduced
by 45 % from 29.0±8 mmHg to 16.1±4 mmHg, in the 45
combined cases by 35 % from 21.7±8 mmHg to 14.2±
3 mmHg after one year. Medication was reduced by 29 %
and 36 %, respectively.
The published results are in agreement with the results
from our study in terms of overall reduction in IOP and
medications (25 % and 43 % for POAG and 30 % and 44 %
for XFG, respectively). In a Cox proportional hazards model
correcting for age and lens-state, in our study group there was
a significant superiority in terms of sparing further glaucoma
surgery for the combined Trabectome + phaco surgery in
comparison with Trabectome surgery alone in eyes being
either phakic or pseudophakic at the time of operation. The
better IOP-lowering effect might in part be caused by the
phacoemulsification in its own right. This could bias our
finding. However, the Cox proportional hazards model took
the pseudophakic state as the reference level. This rules out the
intraocular lens as confounder.
Of all eyes that failed, 56 eyes of 54 patients underwent
mitomycin-C augmented filtration surgery, i.e., trabeculectomy.
It is reported in the literature, that filtration surgery after
Trabectome surgery is not affected in its surgical outcome and
success rates [5]. We also did not see a higher complication or
failure rate than that reported in the literature for primary
mitomycin-C augmented trabeculectomy [6–8].
As Trabectome surgery does not alter the ocular surface
(this in contrast to nonpenetrating glaucoma surgery, filtration
surgery or drainage implants), it is of particular interest for all
patients suffering from immunologic ocular surface diseases
or having undergone penetrating keratoplasty. Further, it is
known from the literature that over 80 % of glaucoma patients
suffer from severe ocular surface disturbances due to chronic
application of several antiglaucoma drops [9–11]. Early,
minimal invasive surgery might be a good opportunity to ease
and improve the therapy for those patients [12, 13].
Glaucoma surgery of the juxtacanalicular trabecular
meshwork aims to overcome the outflow resistance of a
pathologically altered tissue[14]. Morphological changes of
extracellular matrix and trabecular cells have been well
characterized [15–18]. With the Trabectome, the scleral wall
of Schlemm’s canal with its collector channel openings is
exposed to direct aqueous flow. The theory that the main
outflow resistance lies in the inner wall of Schlemm’s canal
would suggest an inevitable, significant IOP reduction after
surgery. Yet, all clinical data show limited success rates in
almost all forms of open angle glaucoma. It is of particular
interest that patients with a widely opened Schlemm’s canal
on gonioscopy and OCT can present with both target as well
as high IOP levels. The introduction of high-resolution
imaging techniques has led to new insights into the anatomical
structures beyond Schlemm’s canal. Applying both Micro-CT
and spectral-domain OCT on human eyes, they are able to
reveal highly complex patterns of collector channels as well as
very irregular intracleral-and episcleral outflow vessels
[19–21]. Further experimental studies will be essential to
better understand the transport and resorption of aqueous
humor across the collector channels and the complex
downstream draining and vascular system. This knowledge
will be crucial to better understand and predict success and
failure of angle surgery with the Trabectome.
Due to the study design as a prospective observational
study with the focus on the effectiveness of the Trabectome
in different forms of open angle glaucomas, there was no
randomization and no control population included. One
limitation of this study is the inclusion of both eyes of several
individuals (n =70 among all subgroups). Nevertheless, their
absolute numbers among the POAG and XFG groups are too
small to cause statistically significant interference. Further, the
limited numbers in many of the investigated subgroups might
be a limiting factor of this study. Therefore, these subgroups
have been excluded from statistical analysis. However, in
Table 2 Cox proportional hazards model for surgical failure (POAG and
XFG). Reference is pseudophacic lens state at time of surgery. Combined
surgery (Trabectome + Cataract) significantly lowers the risk for surgical
failure in comparison to pseudophakic patients. There is a trend towards
increasing age being beneficial for a successful surgical outcome. HR –
Hazard Ratio, CI – Confidence Interval, phakic – phakic at time of
Trabectome surgery, combined – Trabectome + phaco, age – age at time
of surgery. Statistical significance was assumed for p <0.05
HR CI lower 95 CI upper 95 p
Phakic 1.12 0.54 2.29 0.759
Combined 0.20 0.07 0.62 0.005
Age 0.98 0.96 1.01 0.242
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order to prevent publication bias, evaluating a relational
database requires to at least descriptively reporting all data
available. More data is required to further validate our first
results and trends.
The results of our study confirm that minimal invasive
glaucoma surgery with the Trabectome offers a valuable
addition to the armamentarium of glaucoma surgery. The
confirmation is convincing because of the facts of a fast
operation in topical anesthesia, the low risk and complication
profile, and the remaining option for filtration surgery, if
necessary. The achievable target pressure makes it a good option
for early surgery in eyes with moderate optic disc damage. It
might also be considered to reduce topical antiglaucomatous
therapy. Consequently, it should not be seen as an alternative to
filtration surgery in advanced cases, neither regarding the
achievable target pressure nor the definition of surgical success.
It proved to be a good option for the combined cataract–
glaucoma surgery.
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